| Update on Active Surveillance |
Tony Finelli |
VIEW |
| Prostate MRI and Fusion Biopsy |
Sangeet Ghai |
VIEW |
| Prostate Biomarkers |
Alex Zlotta |
VIEW |
| PET Scan and Molecular Imaging |
Rob Hamilton |
VIEW |
| Biologic Rational for Treating Oligometastases |
Neil Fleshner |
VIEW |
| Update on Bone Targeted Therapies |
Neil Fleshner |
VIEW |
| Future Directions for the Management of mCRPC |
Rob Hamilton |
VIEW |
| Renal Tumour Biopsy and Active Surveillance for Small Renal Masses |
Tony Finelli |
VIEW |
| Neoadjuvant and adjuvant therapy for high risk Renal Cell Carcinoma |
Anil Kapoor |
VIEW |
| OMA Presentation |
John Kell |
VIEW |
| Update on Intravesical Therapies and Clinical Trials |
Girish Kulkarni |
VIEW |
| New Molecular Grading in Bladder Cancer |
Alex Zlotta |
VIEW |
| ERAS for Patients Undergoing Cystectomy |
Munir Jamal |
VIEW |
| DEBATE: Neoadjuvant versus Adjuvant Chemotherapy for Invasive Bladder Cancer |
Alex Zlotta |
VIEW |
| Update on Superficial Penal Cancer |
Zachary Klinghoffer |
VIEW |
| Hemorrhagic Cystitis - How to Mend a Bleeding Bladder |
Ashis-Chawla |
VIEW |
